Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Phase 1 Unknown
100 enrolled
DIPG
Phase 2 Unknown
54 enrolled
CLTBME
Unknown
2,000 enrolled
Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis
Phase NA Unknown
100 enrolled
A Study to Assess the Efficacy of Cerebellar IMRT Combined With Cerebral SRS in Patients With Brain Metastases
Phase NA Unknown
37 enrolled
MuRaLM
Unknown
178 enrolled
Chronotherapy for Radiotherapy of Glioma
Unknown
80 enrolled
HSCK-010
Phase 1/2 Unknown
50 enrolled
Study of DC Vaccination Against Glioblastoma
Phase 2 Unknown
100 enrolled
Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
Phase 3 Unknown
369 enrolled
Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Phase 1/2 Unknown
50 enrolled
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma
Phase 2 Unknown
464 enrolled
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
Phase NA Unknown
10 enrolled
RSMA2010
Phase 2 Unknown
97 enrolled
Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer
Phase 2 Unknown
44 enrolled
SMC 0712-13
Phase 1 Unknown
18 enrolled
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M
Phase 3 Unknown
150 enrolled
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
Phase 2 Unknown
45 enrolled
Response-based Treatment of High-risk Neuroblastoma
Phase 2 Unknown
54 enrolled
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Phase NA Unknown
20 enrolled
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Phase 3 Unknown
316 enrolled
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Phase 2 Unknown
25 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
Phase 2 Unknown
24 enrolled
Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
Phase 2 Unknown
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
Phase 3 Unknown
120 enrolled
Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
Phase 3 Unknown
200 enrolled
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Unknown
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
Phase 3 Unknown
270 enrolled
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
Phase 1 Unknown
48 enrolled
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Phase 2 Unknown
29 enrolled
Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
Phase 3 Unknown
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
Phase NA Unknown
120 enrolled
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
Phase 2 Unknown
87 enrolled
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
Phase 2 Unknown
43 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma
Phase 2 Unknown
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Phase 3 Unknown
642 enrolled
Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors
Phase 2 Unknown
30 enrolled
Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma
Phase 3 Unknown
30 enrolled
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
Phase 3 Unknown
GLIAA
Phase 2 Unknown
200 enrolled
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
Phase 1 Unknown
30 enrolled
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
Phase 2 Unknown
100 enrolled
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Phase 1/2 Unknown
46 enrolled